Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 8

    Ananth Narayanan joins Medlife as co-founder and CEO

    Ananth Narayanan joins Medlife as co-founder and CEO

    Medical Dialogues Bureau6 Aug 2019 4:34 PM IST
    New Delhi: Online health platform Medlife on Monday said former Myntra-Jabong CEO Ananth Narayanan has joined the company as its chief executive...
    Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

    Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

    Medical Dialogues Bureau5 Aug 2019 9:30 AM IST
    Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to...
    Enforcement Directorate raids premises of ex-Ranbaxy/Fortis Promoters on allegations of money laundering

    Enforcement Directorate raids premises of ex-Ranbaxy/Fortis Promoters on allegations of money laundering

    Medical Dialogues Bureau2 Aug 2019 11:40 AM IST
    They said the raids were conducted at seven locations in Delhi including those connected to the Singh brothers, ex-CMD of Religare Enterprises Ltd...
    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Medical Dialogues Bureau29 July 2019 9:00 AM IST
    Patna: Mumbai-based drugmaker, Alkem Laboratories Founder and Chairman Emeritus, Samprada Singh expired on Saturday at the age of 92 years after a...
    Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

    Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

    Medical Dialogues Bureau28 July 2019 9:30 AM IST
    The objective is to spread the natural healing touch of Unani and reach out to people wanting natural, herbal treatment for lifestyle diseases, and a...
    Man dies after Pharmacist administers painkiller injection; case booked

    Man dies after Pharmacist administers painkiller injection; case booked

    Farhat Nasim25 July 2019 4:44 PM IST
    Chennai: A 52 years old pharmacist has been arrested following the death of a man who was administered a painkiller injection by him. According to...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    GSK Pharma Q1 net profit up 35 percent at Rs 113 crore in FY20

    GSK Pharma Q1 net profit up 35 percent at Rs 113 crore in FY20

    Medical Dialogues Bureau23 July 2019 9:45 AM IST
    Mumbai: GlaxoSmithKline (GSK) Pharmaceuticals on Monday announced a 35 per cent jump in its net profit to Rs 113.5 crore during the first quarter of...
    Different claims used by PATANJALI for marketing in India and abroad: USFDA

    Different claims used by PATANJALI for marketing in India and abroad: USFDA

    Medical Dialogues Bureau22 July 2019 1:44 PM IST
    "I observed that the 'Bel Sharbat' and 'Gulab Sharbat' products are sold under the PATANJALI brand name for domestic (India) and international (USA)...
    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Medical Dialogues Bureau21 July 2019 4:30 PM IST
    Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
    HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

    HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

    Medical Dialogues Bureau19 July 2019 4:55 PM IST
    New Delhi: The Delhi High Court Wednesday termed as "a racket" the submission of a private company, directed to plant 1.4 lakh saplings worth Rs 80...
    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 10:02 AM IST
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok